Variant report

Variant	esv1009068
Chromosome Location	chr1:113048992-113057407
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:209)
CpG islands
(count:976)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:209 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr1:113051104-113051472	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr1:113051209-113051411	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr1:113051132-113051484	GM12878	blood:	n/a	n/a
4	BHLHE40	chr1:113051210-113051267	K562	blood:	n/a	n/a
5	BRCA1	chr1:113051162-113051356	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr1:113051134-113051503	Hela-S3	cervix:	n/a	n/a
7	CHD2	chr1:113051261-113051354	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD2	chr1:113050626-113050657	Hela-S3	cervix:	n/a	n/a
9	CHD2	chr1:113051038-113051040	HepG2	liver:	n/a	n/a
10	CHD2	chr1:113051056-113051411	GM12878	blood:	n/a	n/a
11	CREB1	chr1:113051086-113051591	H1-hESC	embryonic stem cell:	n/a	n/a
12	CREB1	chr1:113051205-113051441	A549	lung:	n/a	n/a
13	CTBP2	chr1:113049984-113052188	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr1:113051324-113051377	NHEK	skin:	n/a	chr1:113051361-113051374
15	CTCF	chr1:113051260-113051410	AG04449	skin:	n/a	chr1:113051361-113051374
16	CTCF	chr1:113051291-113051370	GM19240	blood:	n/a	n/a
17	CTCF	chr1:113051240-113051390	SAEC	small airway:	n/a	chr1:113051361-113051374
18	CTCF	chr1:113051315-113051392	GM10248	blood:	n/a	chr1:113051361-113051374
19	CTCF	chr1:113051260-113051410	GM06990	blood:	n/a	chr1:113051361-113051374
20	CTCF	chr1:113051260-113051410	NHEK	skin:	n/a	chr1:113051361-113051374
21	CTCF	chr1:113051380-113051530	GM12868	blood:	n/a	n/a
22	CTCF	chr1:113051220-113051370	AG04449	skin:	n/a	n/a
23	CTCF	chr1:113051327-113051360	MCF-7	breast:	n/a	n/a
24	CTCF	chr1:113051287-113051420	GM19239	blood:	n/a	chr1:113051361-113051374
25	CTCF	chr1:113051300-113051450	Hela-S3	cervix:	n/a	chr1:113051361-113051374
26	CTCF	chr1:113051240-113051390	Caco-2	colon:	n/a	chr1:113051361-113051374
27	CTCF	chr1:113051100-113051390	GM12864	blood:	n/a	chr1:113051361-113051374
28	CTCF	chr1:113051240-113051390	GM12874	blood:	n/a	chr1:113051361-113051374
29	CTCF	chr1:113051233-113051540	K562	blood:	n/a	chr1:113051361-113051374
30	CTCF	chr1:113051320-113051470	HMEC	breast:	n/a	chr1:113051361-113051374
31	CTCF	chr1:113051307-113051365	Hela-S3	cervix:	n/a	n/a
32	CTCF	chr1:113051260-113051410	GM12874	blood:	n/a	chr1:113051361-113051374
33	CTCF	chr1:113051260-113051410	GM12873	blood:	n/a	chr1:113051361-113051374
34	CTCF	chr1:113051304-113051390	Pancreas_OC	pancreas:	n/a	chr1:113051361-113051374
35	CTCF	chr1:113051200-113051350	GM12878	blood:	n/a	n/a
36	CTCF	chr1:113051081-113051112	GM12891	blood:	n/a	n/a
37	CTCF	chr1:113051300-113051450	GM12873	blood:	n/a	chr1:113051361-113051374
38	CTCF	chr1:113051260-113051410	GM12865	blood:	n/a	chr1:113051361-113051374
39	CTCF	chr1:113051260-113051410	GM12866	blood:	n/a	chr1:113051361-113051374
40	CTCF	chr1:113050960-113051110	GM12866	blood:	n/a	n/a
41	CTCF	chr1:113051240-113051447	K562	blood:	n/a	chr1:113051361-113051374
42	CTCF	chr1:113051200-113051350	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr1:113051600-113051750	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr1:113051240-113051390	HEK293	kidney:	n/a	chr1:113051361-113051374
45	CTCF	chr1:113050640-113050790	HCPEpiC	choroid plexus:	n/a	chr1:113050755-113050768
46	CTCF	chr1:113051265-113051271	GM19239	blood:	n/a	n/a
47	CTCF	chr1:113051240-113051390	GM12871	blood:	n/a	chr1:113051361-113051374
48	CTCF	chr1:113051301-113051394	MCF-7	breast:	n/a	chr1:113051361-113051374
49	CTCF	chr1:113051180-113051330	HCFaa	heart:	n/a	n/a
50	CTCF	chr1:113051180-113051330	HCM	heart:	n/a	n/a

(count:976 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:113050814-113050864	HIPEpiC	eye:	n/a
2	chr1:113051090-113051140	RPTEC	kidney:	n/a
3	chr1:113051043-113051093	IMR90	lung:	fetal
4	chr1:113051139-113051189	MCF10A-Er-Src	breast:	n/a
5	chr1:113050539-113050589	GM19239	blood:	n/a
6	chr1:113051846-113051896	GM12892	blood:	n/a
7	chr1:113051353-113051403	PrEC	prostate:	n/a
8	chr1:113051315-113051365	IMR90	lung:	fetal
9	chr1:113051925-113051975	LNCaP	prostate:	n/a
10	chr1:113051685-113051735	GM12891	blood:	n/a
11	chr1:113051846-113051896	CMK	blood:	n/a
12	chr1:113051043-113051093	NB4	blood:	n/a
13	chr1:113051315-113051365	NHBE	bronchial:	n/a
14	chr1:113051925-113051975	GM12878	blood:	n/a
15	chr1:113051090-113051140	ovcar-3	ovarian:	n/a
16	chr1:113051685-113051735	ProgFib	skin:	n/a
17	chr1:113051315-113051365	K562	blood:	n/a
18	chr1:113050814-113050864	U87	brain:	n/a
19	chr1:113051171-113051221	HL-60	blood:	n/a
20	chr1:113056151-113056201	IMR90	lung:	fetal
21	chr1:113050814-113050864	ovcar-3	ovarian:	n/a
22	chr1:113052167-113052217	SK-N-MC	brain:	n/a
23	chr1:113051043-113051093	HEK293	kidney:	embryo
24	chr1:113051315-113051365	T-47D	breast:	n/a
25	chr1:113051846-113051896	PFSK-1	brain:	n/a
26	chr1:113052167-113052217	HUVEC	blood vessel:	n/a
27	chr1:113051685-113051735	MCF-7	breast:	n/a
28	chr1:113051090-113051140	K562	blood:	n/a
29	chr1:113051925-113051975	GM12892	blood:	n/a
30	chr1:113052167-113052217	NH-A	brain:	n/a
31	chr1:113051846-113051896	MCF10A-Er-Src	breast:	n/a
32	chr1:113051171-113051221	HIPEpiC	eye:	n/a
33	chr1:113051777-113051827	BE2_C	brain:	n/a
34	chr1:113052563-113052613	Caco-2	colon:	n/a
35	chr1:113056151-113056201	HCF	heart:	n/a
36	chr1:113052167-113052217	HMEC	breast:	n/a
37	chr1:113051171-113051221	AG04449	skin:	fetal
38	chr1:113050814-113050864	NB4	blood:	n/a
39	chr1:113051777-113051827	ECC-1	luminal epithelium:	n/a
40	chr1:113051977-113052027	T-47D	breast:	n/a
41	chr1:113052563-113052613	A549	lung:	n/a
42	chr1:113051315-113051365	A549	lung:	n/a
43	chr1:113051685-113051735	BE2_C	brain:	n/a
44	chr1:113050539-113050589	HEK293	kidney:	embryo
45	chr1:113051925-113051975	BE2_C	brain:	n/a
46	chr1:113051353-113051403	GM12892	blood:	n/a
47	chr1:113056151-113056201	K562	blood:	n/a
48	chr1:113051139-113051189	HCT-116	colon:	n/a
49	chr1:113052167-113052217	T-47D	breast:	n/a
50	chr1:113056151-113056201	NHDF-neo	bronchial:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:113044387..113046932-chr1:113047303..113049835,3	K562	blood:
2	chr1:113042549..113044879-chr1:113047286..113049813,2	MCF-7	breast:
3	chr1:113050916..113052536-chr1:113056260..113057826,2	K562	blood:
4	chr1:113053258..113055489-chr1:113072240..113074967,2	MCF-7	breast:
5	chr1:113050916..113052536-chr1:113056260..113057826,2	K562	blood:
6	chr1:113053649..113055695-chr1:113241407..113243136,2	K562	blood:
7	chr1:112937399..112939003-chr1:113054969..113056954,2	MCF-7	breast:
8	chr1:113050070..113052532-chr1:113159337..113161675,2	MCF-7	breast:
9	chr1:113048065..113050562-chr1:113256191..113259414,3	MCF-7	breast:
10	chr1:113051455..113054966-chr1:113056475..113060104,3	MCF-7	breast:

No data

Variant related genes	Relation type
WNT2B	TF binding region
WNT2B	CpG island
ENSG00000261595	chromatin interactions
ENSG00000155363	chromatin interactions
ENSG00000007341	chromatin interactions
ENSG00000155367	chromatin interactions
ENSG00000134245	chromatin interactions
ENSG00000143079	chromatin interactions

Extended variants
information (count: 280 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:280 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs187701173	chr1:113049014-113049015	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs192360848	chr1:113049041-113049042	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs562239540	chr1:113049042-113049043	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs539170778	chr1:113049156-113049157	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs114261661	chr1:113049163-113049164	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs368897479	chr1:113049247-113049248	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs561675977	chr1:113049429-113049430	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs527612185	chr1:113049457-113049458	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs547637984	chr1:113049506-113049507	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs371488525	chr1:113049613-113049614	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs351366	chr1:113049651-113049652	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs539574815	chr1:113049652-113049653	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs552752470	chr1:113049687-113049688	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs569367101	chr1:113049688-113049689	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs183681312	chr1:113049715-113049716	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs555022152	chr1:113049730-113049731	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs569347317	chr1:113049815-113049816	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs568405952	chr1:113049825-113049826	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs351367	chr1:113049862-113049863	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs544763601	chr1:113049863-113049864	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs115644003	chr1:113049881-113049882	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs545976079	chr1:113049886-113049887	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs142173203	chr1:113049891-113049892	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs201111047	chr1:113049933-113049934	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs351368	chr1:113049941-113049942	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs115002283	chr1:113050000-113050001	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs56936763	chr1:113050030-113050031	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs143808747	chr1:113050034-113050035	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs540970850	chr1:113050054-113050055	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs148177373	chr1:113050057-113050058	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs533021870	chr1:113050103-113050104	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs141147428	chr1:113050119-113050120	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs116966955	chr1:113050134-113050135	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs1777613	chr1:113050174-113050175	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs548658674	chr1:113050190-113050191	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs373526237	chr1:113050232-113050233	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs568364237	chr1:113050238-113050239	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs375761020	chr1:113050255-113050256	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs12725279	chr1:113050275-113050276	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs541327834	chr1:113050280-113050281	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs376777058	chr1:113050337-113050338	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs571107923	chr1:113050345-113050346	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs114553387	chr1:113050357-113050358	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs556361073	chr1:113050385-113050386	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs576195534	chr1:113050390-113050391	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs79473160	chr1:113050406-113050407	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs189260977	chr1:113050412-113050413	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs571995479	chr1:113050449-113050450	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs139467588	chr1:113050454-113050455	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs564261378	chr1:113050473-113050474	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Astrocytoma	17934521	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Multiple myeloma	16461302	CNVD
Cancer	21129771	CNVD
Autosomal dominant nocturnal frontal lobe epilepsy	18472482	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Thrombocytopenia-absent radius syndrome	21933853	CNVD
Psychiatric disorder	22848183	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	20409316	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17393978	CNVD
Medulloblastoma	21979893	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Rett syndrome	21593744	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21720365	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Pancreatic endocrine tumor	17639061	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	17550852	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Asthma	20841430	CNVD
Aetanephric adenomas	20802469	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Systemic lupus erythematosus	21956041	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	16573809	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Breast cancer	17899364	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Melanoma	19671679	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	22522925	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:529 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:113045000-113050600	Weak transcription	Placenta Amnion	Placenta Amnion
2	chr1:113045000-113050600	Weak transcription	Spleen	Spleen
3	chr1:113045200-113050400	Weak transcription	Lung	lung
4	chr1:113045200-113050400	Enhancers	Ovary	ovary
5	chr1:113045400-113050400	Weak transcription	A549	lung
6	chr1:113045400-113050600	Bivalent Enhancer	Fetal Stomach	stomach
7	chr1:113045600-113050600	Weak transcription	Esophagus	oesophagus
8	chr1:113045600-113050600	Weak transcription	Gastric	stomach
9	chr1:113047000-113049200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
10	chr1:113047600-113049600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr1:113047600-113049800	Enhancers	Primary B cells from peripheral blood	blood
12	chr1:113048000-113050400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
13	chr1:113048200-113050400	Weak transcription	Rectal Mucosa Donor 31	rectum
14	chr1:113048800-113049000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr1:113048800-113050200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr1:113049000-113049200	Bivalent Enhancer	Fetal Muscle Leg	muscle
17	chr1:113049200-113049400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr1:113049200-113049400	Bivalent Enhancer	Stomach Mucosa	stomach
19	chr1:113049400-113049600	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr1:113049400-113049600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
21	chr1:113049400-113049600	Bivalent Enhancer	Stomach Smooth Muscle	stomach
22	chr1:113049400-113050000	Weak transcription	Hela-S3	cervix
23	chr1:113049400-113050400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr1:113049600-113049800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
25	chr1:113049600-113049800	Bivalent/Poised TSS	Primary T helper naive cells fromperipheralblood	blood
26	chr1:113049600-113049800	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
27	chr1:113049600-113050000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
28	chr1:113049600-113050200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
29	chr1:113049600-113050200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
30	chr1:113049600-113050200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
31	chr1:113049600-113050200	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
32	chr1:113049600-113050400	Enhancers	Primary T helper naive cells from peripheral blood	blood
33	chr1:113049600-113050600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr1:113049800-113050200	Enhancers	Primary T helper cells fromperipheralblood	blood
35	chr1:113049800-113050400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
36	chr1:113049800-113050400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
37	chr1:113049800-113050600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
38	chr1:113050000-113050200	Enhancers	Hela-S3	cervix
39	chr1:113050000-113050400	Bivalent Enhancer	Primary B cells from cord blood	blood
40	chr1:113050000-113050400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
41	chr1:113050000-113050400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
42	chr1:113050000-113050400	Enhancers	Right Ventricle	heart
43	chr1:113050000-113052400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
44	chr1:113050200-113050400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
45	chr1:113050200-113050400	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
46	chr1:113050200-113050400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
47	chr1:113050200-113050400	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
48	chr1:113050200-113050400	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
49	chr1:113050200-113050400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr1:113050200-113050400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links